Prostate Cancer - Results from #22580

Shared decision making in prostate-specific antigen testing: The effect of a mailed patient flyer prior to an annual exam - Abstract August 7, 2013

Use of advanced treatment technologies among men at low risk of dying from prostate cancer - Abstract August 7, 2013

Differences in prostate cancer detection between Canadian and Saudi populations - Abstract August 7, 2013

International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens - Abstract August 7, 2013

Assessing follow-up care after prostate-specific antigen elevation in American Indian / Alaska Native Men: A partnership approach - Abstract August 7, 2013

Non-invasive diagnosis of prostate cancer: Serum and urine markers - Abstract August 7, 2013

Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care - Abstract August 7, 2013

Causes of death in men with prostate cancer: An analysis of 50 000 men from the Thames Cancer Registry - Abstract August 7, 2013

A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer - Abstract August 6, 2013

Is mechanical bowel preparation in laparoscopic radical prostatectomy beneficial? An analysis of a Japanese national database - Abstract August 6, 2013

The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level August 6, 2013

Does (11)C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation? - Abstract August 6, 2013

Overview of the latest treatments for castration-resistant prostate cancer - Abstract August 6, 2013

Abiraterone for the treatment of advanced prostate cancer - Abstract August 6, 2013

Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging - Abstract August 5, 2013

A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy - Abstract August 5, 2013

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer - Abstract August 5, 2013

Contrast-ultrasound dispersion imaging for prostate cancer localization by improved spatiotemporal similarity analysis - Abstract August 5, 2013

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT - Abstract August 5, 2013

Immunotherapy in a mCRPC patient: The large urology group experience - Video Lecture - by Christopher M. Pieczonka, MD August 5, 2013

Page 1130 of 1436